Neuronetics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers out of Level 3 (Deprecated 2019-01-31)
Neuronetics, Inc. (STIM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers out of Level 3 (Deprecated 2019-01-31) of $1.87 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-05.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersOutOfLevel3 · last filed 2019-03-05
- Neuronetics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, instruments classified in shareholders' equity, transfers out of level 3 (deprecated 2019-01-31) for the quarter ending 2018-12-31 was $0.00.
- Neuronetics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, instruments classified in shareholders' equity, transfers out of level 3 (deprecated 2019-01-31) for fiscal 2018 was $1.87M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers out of Level 3 (Deprecated 2019-01-31) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers out of Level 3 (Deprecated 2019-01-31) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Transfers out of Level 3 (Deprecated 2019-01-31) 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $1.87M 10-K · filed 2019-03-05 | |
| 2018-09-30 | $1.87M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |